Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 12, 2007, Pages 2547-2549

  Zwaginga, Japp J ^a,i   Sakariassen, K S ^b   King, M R ^c   Diacovo, T G ^d   Grabowski, E F ^e   Nash, G ^f   Hoylaerts, M ^g   Heemskerk, J W M ^h  

^a SANQUIN RESEARCH   (Netherlands)

^b KellSa sas   (Italy)

^c University of Rochester   (United States)

^d Department of Medicine   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD FLOW VELOCITY; BLOOD FLOWMETRY; HEMATOCRIT; HUMAN; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SHEAR RATE; THROMBOCYTE ADHESIVENESS; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBOSIS; VON WILLEBRAND DISEASE;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CALIBRATION; EQUIPMENT DESIGN; HUMANS; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; STRESS, MECHANICAL; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 36349004705     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02807.x     Document Type: Article

References (9)

1. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006; 108:1903-10.
2. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: Towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88:94-108.
3. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4:2103-14.
4. Zwaginga JJ, Nash G, King MR, Heemskerk JWM, Frojmovic M, Hoylaerts M, Sakariassen KS. Flow-based assays for global assessment of haemostasis. Part 1: Biorheologic considerations. J Thromb Haemost 2006; 4:2486-7.
5. Weiss HJ, Baumgartner HR, Tschopp TB, Turitto VT, Cohen D. Correction by factor VIII of the impaired platelet adherence to subendothelium in von Willebrand's disease. Blood 1978; 51:267-79.
6. Fressinaud E, Sakariassen KS, Rothschild C, Baumgartner HR, Meyer D. Shear rate dependent impairment of thrombus growth on collagen in non-anticoagulated blood from patients with von Willebrand disease and hemophilia. Blood 1992; 80:988-94.
7. Cattaneo M, Federici AB, Lecchi A, Agati B, Lombardi R, Stabile F, Bucciarelli P. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82:35-9.
8. Lubetsky AJ, Luboshits J, Kenet G, Shenkman B, Tamarin I, Martinowitz U, Varon D. Monitoring vWF replacement therapy: Comparison of CPA to a standard method. Blood 2000; 96:59b.
9. Nishida H, Murata M, Miyaki K, Omae K, Watanabe K, Ikeda Y. Gorog thrombosis test: Analysis of factors influencing occlusive thrombus formation. Blood Coagul Fibrinol 2006; 17:203-7.